The Annual Stephen Hawking MND Lectures were launched in 2017 – and are now an established and important part of the Association’s calendar.

The aim of the Annual Stephen Hawking MND Lecture is to bring current research in motor neurone disease to members of the multidisciplinary team and demonstrate how this might feed into their practice. Lectures are led by experts in their field, and these engaging and popular events attract hundreds of health and social care professionals, including delegates from across Europe. The lectures are held in the evening and online to make attendance as open as possible.

Our thanks to the Stephen Hawking Foundation for their funding support.

Registrations open for the 2025 Annual Stephen Hawking MND Lecture: 

Professor Ammar Al-Chalabi

The genetics of motor neurone disease: why does genetics matter for people living with MND?

We are delighted to announce that Professor Ammar Al-Chalabi, Professor of Neurology and Complex Disease Genetics, will deliver this year's lecture. The session will explore the role of genes in MND, including:

  • the relevance of genetics for anyone living with MND, and their family members, including unaffected relatives
  • how genetic testing may help predict or diagnose MND
  • how genetic knowledge is shaping treatments
  • how to discuss genetics in your practice and how to support people with and affected by MND with genetics-related decisions.

The lecture will take place as a hybrid event on 4 November 2025, and it is open to both health and social care professionals and people with MND. It will be live-streamed online and delivered in person at the Royal Society of Medicine in London, where attendees will also have the opportunity to join an evening reception for drinks and networking.

Please note that in-person places are limited due to venue capacity and will be allocated on a first-come, first-served basis. Don't miss out - visit the link below to book your place!

Book your place

Last year's lecture

2024 The importance of psychological care: Acceptance and Commitment Therapy (ACT) – a proven intervention that supports quality of life.

Held on 12 November, the lecture explored the psychological impact of MND, with a focus on Acceptance and Commitment Therapy (ACT), to improve quality of life for people with MND.

The session was led by Rebecca Gould, Professor of Psychological Therapies in the Division of Psychiatry at University College London, and an Honorary Clinical Psychologist at Camden and Islington NHS Foundation Trust.

Her main research interests are in developing and evaluating psychological interventions, particularly third-wave therapies such as ACT and mindfulness-based interventions, for people living with and affected by physical and mental health conditions. Among her recent work, she was the chief investigator of the ground-breaking COMMEND research study - a clinical trial examining the clinical and cost-effectiveness of ACT for improving quality of life in people with motor neurone disease, compared to multidisciplinary usual care.

During the lecture, attendees gained a deeper understanding of the importance of psychological support for people with MND, including the relevant recommendations outlined in NICE Guideline NG42. They were also introduced to the principles of ACT and how these can be applied to their practice in MND care.  

Watch recording 

Previous lectures

You can watch videos of previous lectures below: